These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30909272)

  • 1. Physical Activity and Mobility Differentially Predict Nondemented Executive Function Trajectories: Do Sex and APOE Moderate These Associations?
    Thibeau S; McFall GP; Camicioli R; Dixon RA
    Gerontology; 2019; 65(6):640-648. PubMed ID: 30909272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's Disease Biomarkers Interactively Influence Physical Activity, Mobility, and Cognition Associations in a Non-Demented Aging Population.
    Thibeau S; McFall GP; Camicioli R; Dixon RA
    J Alzheimers Dis; 2017; 60(1):69-86. PubMed ID: 28800331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-reducing Apolipoprotein E and Clusterin genotypes protect against the consequences of poor vascular health on executive function performance and change in nondemented older adults.
    McFall GP; Sapkota S; McDermott KL; Dixon RA
    Neurobiol Aging; 2016 Jun; 42():91-100. PubMed ID: 27143425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frailty effects on non-demented cognitive trajectories are moderated by sex and Alzheimer's genetic risk.
    Thibeau S; McDermott K; McFall GP; Rockwood K; Dixon RA
    Alzheimers Res Ther; 2019 Jun; 11(1):55. PubMed ID: 31221191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic factors moderate everyday physical activity effects on executive functions in aging: Evidence from the Victoria Longitudinal Study.
    Thibeau S; McFall GP; Wiebe SA; Anstey KJ; Dixon RA
    Neuropsychology; 2016 Jan; 30(1):6-17. PubMed ID: 26710092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuances in Alzheimer's Genetic Risk Reveal Differential Predictions of Non-demented Memory Aging Trajectories: Selective Patterns by APOE Genotype and Sex.
    McFall GP; Bäckman L; Dixon RA
    Curr Alzheimer Res; 2019; 16(4):302-315. PubMed ID: 30873923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.
    Sapkota S; Dixon RA
    J Alzheimers Dis; 2018; 62(2):887-900. PubMed ID: 29480189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyle.
    Sapkota S; Bäckman L; Dixon RA
    Neurobiol Aging; 2017 Apr; 52():81-89. PubMed ID: 28131014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Cognitive Decline in Alzheimer's Disease Is Predicted by Changes in Ventricular Size but Moderated by Apolipoprotein E and Pulse Pressure.
    Sapkota S; McFall GP; Masellis M; Dixon RA; Black SE
    J Alzheimers Dis; 2022; 85(2):545-560. PubMed ID: 34864669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multimodal Risk Network Predicts Executive Function Trajectories in Non-demented Aging.
    Sapkota S; McFall GP; Masellis M; Dixon RA
    Front Aging Neurosci; 2021; 13():621023. PubMed ID: 34603005
    [No Abstract]   [Full Text] [Related]  

  • 11. Integrating Three Characteristics of Executive Function in Non-Demented Aging: Trajectories, Classification, and Biomarker Predictors.
    Caballero HS; McFall GP; Wiebe SA; Dixon RA
    J Int Neuropsychol Soc; 2021 Feb; 27(2):158-171. PubMed ID: 32772936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the apolipoprotein E genotype with memory performance and executive functioning in cognitively intact elderly.
    Luck T; Then FS; Luppa M; Schroeter ML; Arélin K; Burkhardt R; Thiery J; Löffler M; Villringer A; Riedel-Heller SG
    Neuropsychology; 2015 May; 29(3):382-387. PubMed ID: 25365563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDE (rs6583817) polymorphism and pulse pressure are independently and interactively associated with level and change in executive function in older adults.
    McFall GP; Wiebe SA; Vergote D; Jhamandas J; Westaway D; Dixon RA
    Psychol Aging; 2014 Jun; 29(2):418-430. PubMed ID: 24660790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of APOE on cognitive aging in community-dwelling older adults.
    Reas ET; Laughlin GA; Bergstrom J; Kritz-Silverstein D; Barrett-Connor E; McEvoy LK
    Neuropsychology; 2019 Mar; 33(3):406-416. PubMed ID: 30730162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index predicts cognitive aging trajectories selectively for females: Evidence from the Victoria Longitudinal Study.
    Bohn L; McFall GP; Wiebe SA; Dixon RA
    Neuropsychology; 2020 May; 34(4):388-403. PubMed ID: 31999164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic associations of catechol-O-methyltransferase and brain-derived neurotrophic factor with executive function in aging are selective and modified by apolipoprotein E.
    Sapkota S; Vergote D; Westaway D; Jhamandas J; Dixon RA
    Neurobiol Aging; 2015 Jan; 36(1):249-56. PubMed ID: 25107496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of an APOE promoter polymorphism on human cortical morphology during nondemented aging.
    Chen Y; Li P; Gu B; Liu Z; Li X; Evans AC; Gong G; Zhang Z
    J Neurosci; 2015 Jan; 35(4):1423-31. PubMed ID: 25632120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E and Clusterin can magnify effects of personality vulnerability on declarative memory performance in non-demented older adults.
    Sapkota S; Wiebe SA; Small BJ; Dixon RA
    Int J Geriatr Psychiatry; 2016 May; 31(5):502-9. PubMed ID: 26343804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension moderates the effect of APOE on 21-year cognitive trajectories.
    de Frias CM; Schaie KW; Willis SL
    Psychol Aging; 2014 Jun; 29(2):431-9. PubMed ID: 24956008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.